Review
A Critical Review of the American College of Cardiology/American Heart Association Practice Guidelines on Bicuspid Aortic Valve With Dilated Ascending Aorta

https://doi.org/10.1016/j.amjcard.2008.02.106Get rights and content

The 2006 practice guidelines from the American College of Cardiology and the American Heart Association recommend prophylactic aortic replacement for even an asymptomatic patient with a bicuspid aortic valve (BAV) when the aortic dimensions exceed arbitrary ranges based on Marfan syndrome, without comparing risk estimates of aortic dissection with operative risks. In the International Registry of Acute Aortic Dissection, which includes >1,000 autopsied subjects, the average age is 63 years; BAVs are found in only 3%, compared with histories of hypertension in 72%. The risk for valve-sparing aortic replacement is 4% and that for late mortality is 10%, on the basis of 5 publications. The aortic dimensions are from guidelines for Marfan syndrome, with a proved genetic weakness of connective tissue, whereas no culprit genes have been demonstrated in BAV. Although cystic medial necrosis is seen in dilated aortas associated with Marfan syndrome and BAV, it is also seen in dilated aortas with other causes. There is no convincing proof that cystic medial necrosis causes dissection or is simply an effect of dilatation. BAV is not associated with dilatation of the pulmonary arteries, in contrast to Marfan syndrome. Hemodynamic explanations for dilatation of the ascending aorta have been largely ignored because of a belief that it requires severe aortic stenosis or regurgitation. In conclusion, vascular dilatation without a genetic weakness is caused by coarse periodic vibrations from even trivial valve disorders, demonstrated experimentally. There is a natural history of progressive deterioration of the BAV, including the valve left in a valve-sparing aortic replacement, that makes the operation ill advised, as opposed to valve replacement with aortic reinforcement.

Section snippets

Histopathology Relative to Inheritance

The guidelines assert that the histology associated with aortic dilatation is cystic medial necrosis1 and further that this causes aortic dissection in patients with BAVs. Nataamadja et al2 drew this conclusion because cystic medial necrosis was associated with BAV and Marfan syndrome. Furthermore, they argued that BAV was associated with premature death, with only anecdotal reports. Unlike patients with Marfan syndrome, who have hereditary tissue weakness, a genetic link has not been

Aortic Dissection Populations

Among the patients with dissections of the aorta in the IRAD, only 3% had BAVs and 5% had Marfan syndrome.6 Larson and Edwards5 found that 6% of their 161 patients with dissections had BAVs, and Roberts and Roberts10 found that 7.5% of their 286 patients with dissections had BAVs. In a series of 126 patients who had undergone elective valve-sparing aortic replacement,11 only 3% had BAVs. If one pools the BAV risks weighted by the number of patients in each of these studies, the likelihood of

Poststenotic Dilatation as a Cause of Aortic Dilatation

There is a considerable body of evidence indicating that specific hemodynamics can produce dilatation in all arteries, including central, peripheral, and pulmonary, which is not discussed in the practice guidelines.1 In 1954, Holman15 observed that even minor degrees of obstruction of a normal peripheral artery could cause rough periodic turbulence and that this, rather than the severity of the obstruction, produced the subsequent dilatation by means of tissue fatigue. Aortic regurgitation can

The Natural History of Bicuspid Aortic Valve Relative to Valve-Sparing Surgery

The natural history of BAV is relevant to the timing of surgical intervention for aortic valve replacement, relative to replacement of the aorta. Patients with BAVs demonstrate increasing sclerosis after the second decade and calcification with increasing stenosis beginning by the fourth decade.22 In 1968, Campbell22 reported that the same progression seen in BAV ultimately occurs with a tricuspid aortic valve, but several years later. This deterioration with time in BAV and tricuspid aortic

Other Surgical Considerations

The mortality for aortic root replacement is not trivial, considering that the published statistics are usually from centers of excellence. There is no question that mortality is less when replacement is elective in patients with Marfan syndrome as opposed to those with acute dissections, with or without congestive failure. However, from 5 publications concerning elective replacement11, 23, 24, 25, 26 in 717 patients for a BAV with dilatation, early mortality was 4% (a weighted mean), and total

References (31)

Cited by (90)

  • Diagnostic Pathology: Cardiovascular

    2018, Diagnostic Pathology: Cardiovascular
  • Risk of Aortic Dissection in the Moderately Dilated Ascending Aorta

    2016, Journal of the American College of Cardiology
View all citing articles on Scopus
View full text